REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 1,367,343 Value ($000) $4,157 Avg Close Range
Q3 2024
Shares 1,932,205 Value ($000) $10,028 Avg Close Range
Q2 2024
Shares 107,980 Value ($000) $278 Avg Close Range
Q1 2024
Shares 298,110 Value ($000) $1,467 Avg Close Range
Q4 2023
Shares 411,750 Value ($000) $3,619 Avg Close Range
Q3 2023
Shares 782,016 Value ($000) $8,970 Avg Close Range
Q2 2023
Shares 2,011,669 Value ($000) $50,915 Avg Close Range
Q1 2023
Shares 2,291,911 Value ($000) $73,822 Avg Close Range
Q4 2022
Shares 1,338,920 Value ($000) $24,716 Avg Close Range
Q3 2022
Shares 1,469,573 Value ($000) $39,678 Avg Close Range
Q2 2022
Shares 817,740 Value ($000) $11,302 Avg Close Range
Q1 2022
Shares 846,268 Value ($000) $16,502 Avg Close Range
Q4 2021
Shares 523,918 Value ($000) $8,550 Avg Close Range
Q3 2021
Shares 9,240 Value ($000) $257 Avg Close Range
Q2 2021
Shares 48,087 Value ($000) $1,425 Avg Close Range
Q4 2020
Shares 8,933 Value ($000) $253 Avg Close Range
Q3 2020
Shares 31,584 Value ($000) $794 Avg Close Range
Q2 2020
Shares 11,111 Value ($000) $271 Avg Close Range
Q1 2020
Shares 12,300 Value ($000) $182 Avg Close Range
Q2 2019
Shares 21,686 Value ($000) $281 Avg Close Range
Q1 2019
Shares 29,729 Value ($000) $469 Avg Close Range
Q4 2018
Shares 100,490 Value ($000) $2,023 Avg Close Range
Q3 2018
Shares 65,202 Value ($000) $1,620 Avg Close Range
Q2 2018
Shares 77,994 Value ($000) $2,141 Avg Close Range
Q1 2018
Shares 9,288 Value ($000) $286 Avg Close Range
Q4 2017
Shares 44,172 Value ($000) $1,579 Avg Close Range
Q4 2016
Shares 10,717 Value ($000) $222 Avg Close Range
Q1 2016
Shares 54,621 Value ($000) $954 Avg Close Range
Q4 2015
Shares 159,939 Value ($000) $5,464 Avg Close Range
Q3 2015
Shares 25,400 Value ($000) $756 Avg Close Range
Q2 2015
Shares 41,772 Value ($000) $1,336 Avg Close Range